Drugs / VSV-IFNbetaTYRP1
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03865212 | Jun 2019 → Oct 2025 | cutaneous melanoma, malignant choroid melanoma, metastatic melanoma, mucosal melanoma | Mayo Clinic | Terminated | No outcome recorded Stop: Business |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | VSV-IFNbetaTYRP1 | “Modified Virus VSV-IFNbetaTYRP1 in Treating Patients With Stage III-IV Melanoma” NCT03865212 ↗ |
| Route | Other | “intratumoral (IT) injection” NCT03865212 ↗ |